← FDA Drug Approvals (Drugs@FDA)

RIFAMPIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN LABS LTD · Approved 2008-05-22

Drug application

FDA Application #

ANDA065421

Application type

Abbreviated New Drug Application (Generic)

Brand name

RIFAMPIN

Generic name

RIFAMPIN

Active ingredients

RIFAMPIN

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

MYLAN LABS LTD

Manufacturer

Mylan Institutional LLC

First approval

2008-05-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown